. This technique is based on subtractive hybridization of two DNA populations (tester and driver), followed by specific polymerase chain reaction (PCR) of the differences (tester-specific) between the DNA populations. To gain further insight into the molecular genetic changes that are relevant for the development of osteosarcomas, we have combined CGH and RDA for the analysis of a primary osteosarcoma and its metastasis.
The isolation of DNA fragments that are deleted, rearranged or amplified in tumors can be achieved using the more recently developed technique of representational difference analysis (RDA; Lisitsyn et al., 1993 Lisitsyn et al., ,1995 Lisitsyn, 1995) . This technique is based on subtractive hybridization of two DNA populations (tester and driver), followed by specific polymerase chain reaction (PCR) of the differences (tester-specific) between the DNA populations. To gain further insight into the molecular genetic changes that are relevant for the development of osteosarcomas, we have combined CGH and RDA for the analysis of a primary osteosarcoma and its metastasis.
An osteosarcoma sample (T87) was obtained from the right distal femur of a 15-year-old female patient after chemotherapy. Histopathologic exami nation showed a high-grade medullary osteoblastic, partly fibroblastic osteosarcoma with hyalinization and abundant osteoid formation. No cytogenetic data could be obtained from this tumor. Two years later, the same patient developed a metastasis (T95) in the right ilium, which showed the same histopatho logic characteristics as the primary tumor. Cytoge netic analysis revealed several clonal structural abnormalities, including marker chromosomes: 65,X,-X ,-X, -I,del(l)(p31),add(l)(p36),-2,--2J -2,-3,add(3)(p26),del(4)(pl5)X2,add(4)(pl6),-5, -6 ,a d d (6 )(p 2 5 ),-7 ,-8 ,-9 ,-1 0 ,d e l(1 0 )(p ll),-ll, -1 2 ,-1 3 , -14, -1 5 ,-1 6 , -16, -18,del(18)(pl2), -1 9 ,-2 0 ,-2 1 ,-2 2 , + 21mar [2]. At least four of the marker chromosomes and the abnormal chromo somes add(3)(p26) and add(6)(p25) were clearly recognized in four to six other metaphases.
To characterize the genomic alterations in more detail, we performed CGH as described previously by Forus et al. (1995a,b) . DNAs extracted from the primary tumor and its metastasis were compared to reference D N A isolated from peripheral blood cells of normal control persons. Two sites of overt amplifications could easily be recognized in both the primary tumor and its metastasis, one at 17pl 1.2-12 and one at 19ql2-13 (Fig. 1A) . A mini mum of eight target chromosome homologues was assayed for imbalances using arbitrarily set thresh olds for gains and losses of chromosomal (subre gions, 1.25 and 0.75, respectively (du Manoir et al., 1993 Manoir et al., , 1995 . As was seen before, two regions of gain were detected in both tumors, one on 17p, with the highest ratio value at 17pl 1.2-12, and one on 19q, with the highest ratio value at 19ql2-13 (Fig. IB) . Complete suppression of heterochromatic regions of critical chromosomes (1, 9,16, and 19; Du Manoir etaL, 1995) was observed, indicating that the signal of gain on 19ql2-13 is genuine. Other copy number alterations could not be detected in the tumor DNAs under the stringency conditions applied* Although in this study no cytogenetic data of the primary tumor was available, a genetic comparison of the primary tumor and its metastasis based on CGH results was still possible. We conclude that no CGH-detectable changes appear to have occurred after metastasis of the primary tumor.
Using whole chromosome 17 and 19 painting probes, we performed fluorescence in situ hybridiza tion (FISH ) on metastasis-derived metaphase spreads to localize these sequences within the tumor genome. The paints, detected in different colors, showed hybridization to at least five marker chromosomes (not shown). This indicates that extra material of chromosomes 17 and 19 is cryptically present in these marker chromosomes, which is in agreement with the CGH findings.
With the observed highly abnormal karyotype and the D N A amplifications detected by CGH, we set out to isolate aberrant, in particular, amplified, DNA fragments from the primary tumor via RDA. In the case of amplifications, the isolation of target sequences is based on their relative abundance in the tester, which leads to kinetic enrichment during the RDA procedure, and not on their absence in the driver (Lisitsyn 1995; Lisitsyn et al., 1995) . RDA was performed essentially as described by Lisitsyn et al. (1993 Lisitsyn et al. ( , 1995 using representations of primary tumor D N A (the tester) and of a DNA pool of five unrelated control persons (the driver). Representa tions were made by B gM cleavage of genomic DNA and subsequent PCR amplification using its corre sponding anchor primers (Lisitsyn et aL, 1993) . Agarose gel electrophoresis of difference products after one, two, and three rounds of subtractive hybridization and PCR amplification is shown in Figure 2 . Five clear bands, varying in size from 300 to 500 bp, could be observed in the round 3 difference product, whereas background levels were reduced considerably. These five bands were iso lated out of gel and cloned into plasmids. Subse quently, the cloned fragments were used as probes on Southern blots containing tester and driver (representation and total genomic) DNAs. Two distinct clones (clone 18 of 471 bp and clone 38 of 330 bp, derived from bands 5 and 2, respectively) showed more intense hybridization signals in the tester lanes than in the driver lanes, indicating that these fragments represent amplified sequences as present in the original tumor (Fig. 3) . Also in the metastatic tumor, these sequences appeared to be highly amplified (not shown). Other clones, derived from all five bands, showed similar intensities in ¡98 SIMONS E T AL. (Fig. 4) .
To reconfirm the chromosomal origin of clones 18 and 38 by visualization with FISH, a human YAC library (Anand et al., 1990 ; YAC plugs from UK HGMP Resource Centre) was screened by PCR with the FOR/REV primer sets. One clone 38-positive YAC (19B-A6) of approximately 400 kb was isolated. FISH analysis with this YAC on highresolution normal human m eta phase spreads re vealed positive signals at 19q 12-13.1 only, which is in line with the localization of the corresponding DNA fragment (clone 38) on chromosome 19. In addition, YAC 19B-A6 maps to a region exactly coinciding with the region of amplification as ob served by CGH (Fig. 5) . tester and driver lanes on Southern blots, indicating Subsequently, YAC 19B-A6 was used for interthat they represent sequences that have escaped phase FISH analysis of the metastasis. In all nuclei -600 bp -500 bp -400 bp -300 bp the RDA subtraction.
Clones 18 and 38 were sequenced and, subse quently, compared to known sequences in the Genbank and EMBL databases. No relevant ho mologies could be found for either. To establish the examined (over 50), four separate clusters of mul tiple copy signals could be observed. Examples of tumor nuclei exhibiting these clusters of amplifica tion are shown in Figure 6 . For comparison, two YAC signals on a normal lymphocyte nucleus are also shown. These results confirm that the corre sponding sequences are amplified in the osteosar coma studied.
Although it has not been reported before that the 19ql2-13 region is frequently amplified in osteosar comas, it has recently been found that it is a hot spot for structural abnormalities in these tumors Figure 5 . Chromosomal localization of YAC 19B-A6 by FISH on normal high-resoiutlon metaphase chromosomes. A specific hybridiza tion signal (green) can be seen at 19q 12 -13.1 (arrowheads, left). Chromosomes are counterstained in red (left). Chromosomal identifica tion is performed using computer-inverted DAPI-banding (right). (Bridge et al., 1997) . In addition, this 19q segment has occasionally been shown to be amplified in ovarian cancers (Cheng et 
